
GC74862
SB 220025
Also known as 4-[5-(4-fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidin-2-amine
SB 220025 is a reversible, orally active, cell-permeable, ATP-competitive and selective human p38 MAPK inhibitor (IC50 = 60 nM)
ChemicalCAS165806-53-1MW338.38FormulaC18H19FN6
- CAS number
- 165806-53-1
- Molecular weight
- 338.38
- Formula
- C18H19FN6
- Solubility
- DMSO: 50 mg/mL (147·76 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- VSPFURGQAYMVAN-UHFFFAOYSA-N
- Catalogue number
- GC74862
- Brand
- GLPBIO
Computed properties PubChem CID 5164 · XLogP 1.4 · TPSA 81.7 Ų · H-bond donors 2
- XLogP
- 1.4
- TPSA
- 81.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 3
- Heavy atoms
- 25
SMILES C1CNCCC1N2C=NC(=C2C3=NC(=NC=C3)N)C4=CC=C(C=C4)F
Computed descriptors from PubChem (CID 5164), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il